Sirolimus-related toxicity in stem cell transplantation

被引：11

作者：

Busca, A ^{[1
]}

Locatelli, F ^{[1
]}

Moscato, D ^{[1
]}

Falda, M ^{[1
]}

机构：

[1] Osped San Giovanni Battista Torino, Bone Marrow Transplant Unit, Lab Anal Baldi Riberi, Turin, Italy

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 08期

关键词：

D O I：

10.1016/j.bbmt.2005.04.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：647 / 649

页数：3

相关论文

共 4 条

[1] Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
Benito, AI
Furlong, T
Martin, PJ
Anasetti, C
Appelbaum, FR
Doney, K
Nash, RA
Papayannopoulou, T
Storb, R
Sullivan, KM
Witherspoon, R
Deeg, HJ
[J]. TRANSPLANTATION, 2001, 72 (12) : 1924 - 1929
[2] Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine
Groth, CG
Bäckman, L
Morales, JM
Calne, R
Kreis, H
Lang, P
Touraine, JL
Claesson, K
Campistol, JM
Durand, D
Wramner, L
Brattström, C
Charpentier, B
[J]. TRANSPLANTATION, 1999, 67 (07) : 1036 - 1042
[3] Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
Johnston, LJ
Brown, J
Shizuru, JA
Stockerl-Goldstein, KE
Stuart, MJ
Blume, KG
Negrin, RS
Chao, NJ
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (01) : 47 - 55
[4] Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
Kreis, H
Cisterne, JM
Land, W
Wramner, L
Squifflet, JP
Abramowicz, D
Campistol, JM
Morales, JM
Grinyo, JM
Mourad, G
Berthoux, FC
Brattström, C
Lebranchu, Y
Vialtel, P
[J]. TRANSPLANTATION, 2000, 69 (07) : 1252 - 1260